Floatz logo

Clofarabine

Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome

M.D. Anderson Cancer CenterSmall moleculePhase 3Active
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
81/ 100

Competitive context

78 Active assets in the Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome cohort.

Asset / SponsorPhaseRating
FILGRASTIM
City of Hope Medical Center
Phase 2/3BBB
Cytosin-Arabinosid
National Cancer Institute (NCI)
Phase 3BBB
Daunorubicin
National Cancer Institute (NCI)
Phase 3BBB
Idarubicine
Fred Hutchinson Cancer Center
Phase 2/3BB
ETOPOSIDE
M.D. Anderson Cancer Center
Phase 3BB

View all 50 →

Same molecule, other indications

Clofarabine is also rated in:

acute myeloid leukemia with 11q23 abnormalitiesDormant
BB
Indicative ·
70 / 100
View asset →
acute myeloid leukemia, del(5q31-q32)Dormant
BB
Indicative ·
70 / 100
View asset →
disease related to hematopoietic stem cell transplantDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →